Notice of Intent- Sole Source - Bench Mark Ultra, Bench Mark Ultra Plus, and VENTANA HE 600

The Defense Health Agency (DHA), Northeastern Markets Contracting Division (NM-CD), on behalf of Department of Pathology at Walter Reed National Military Medical Center (WRNMMC), intends to award a firm fixed price contract on a sole source basis to Roche Diagnostics Corporation (cage: 51169).

The anticipated award will be made under the statutory authority permitting Other than Full and Open Competition pursuant to FAR 6.302-1 “Only one responsible source and no other supplies or services will satisfy agency requirements”. The contract is intended to renew the lease for the existing tissue staining systems (Bench Mark Ultra, Bench Mark Ultra Plus, Ventana HE 600), along with its reagents, and any necessary services for proper operation.

Roche Diagnostics Corporation (cage: 51169) is the only vendor that owns the proprietary copyrights of this software and product. This notice of intent is NOT a request for competitive proposals or quotations. Requests for copies of a solicitation in response to this notice will not be honored or acknowledged. Phone calls will not be accepted. A determination by the Government to not compete this proposed action based upon response to this notice is solely within the discretion of the Government.

Information received will be considered solely for the purpose of determining whether conducting a competitive procurement is in the best interest of the Government. Interested parties may identify their interest and capabilities by responding to this notice no later than 9am EST, Friday, March 14, 2025 by email to claudia.a.febresmormontoy.ctr@health.mil and cc: faatalivale.m.teo-lewis.civ@health.mil. All information submitted should support the offeror’s capability to provide the training required and shall be furnished at no cost or obligation to the Government.